ITRM was fluctuating at $1.1287 with small volatility from July 15 till July 21. Then the stock sharply increases to $1.3150 which is the highest one during the last five days. After the sharp rise, the stock slowly fell down and reached $1.2100 for today. The average volume of the company is 12,640,082 shares and the total volume consist of 16,128,593 shares.
Iterum Therapeutics and some staff such as officers and directors are under investigation for the swindle with the company’s securities. On July 1, the company releases the news about the result of the testing from the U.S Food and Drug Administration.
The testing was related to the company’s New Drug Application. During the review, some disadvantages were identified that will not allow a continuation of the drug’s completion. However, the specific disadvantages were not listed and it also was mentioned that the decision is not final so it is under review.
Since 2009 Trevor has been eager to know the causes of financial crises. Right now he is actively searching for the next crisis which will decide the fate of the middle class in the Americas and Europe. We wish him good luck in his research.